FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacology, namely to pharmaceutical composition applied for external and local treatment of pyodestructive processes in skin and mucous membranes and characterised by that it contains Tilorone and at least one end additive chosen from: agent with antibacterial activity to gram-positive and/or gram-negative bacteria, antimicotic, local anaesthetic agent, reparative stimulator, hypooxidant, biogenic elements, a base or their mixture in certain ratio.
EFFECT: invention ensures extended application of the known active agent Tilorone, restored local immunity and biocoenosis of skin and mucous membranes in treatment of pyodestructive processes, anaesthetic effect; additional reparative stimulation; improved microcirculation in lesion focus, reduced inflammatory reactions in skin and mucous membranes, decreased secondary tissue neurosis of the affected areas, improved microcirculation in lesion focus, reduced itching, maintained high therapeutic activity and usability, more rapid and improved healing.
10 cl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION ON BASIS OF LOW-MOLECULAR INDUCTOR OF INTERFERON | 2007 |
|
RU2352330C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL APPLICATION BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2351322C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369387C2 |
| PHARMACEUTICAL INJECTION COMPOSITION ON BASIS OF TILORONE FOR TREATMENT OF PURULENT-DESTRUCTIVE PROCESSES WITH SIGNS OF IMMUNE INSUFFICIENCY | 2007 |
|
RU2359664C1 |
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
| STEPHAGLABRIN-BASED PHARMACEUTICAL COMPOSITION OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF TRAUMATIC AND POST-OPERATION INJURY OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2371172C2 |
| ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
